This study investigates advanced gastrointestinal tumors. The purpose of this study is to explore the effects of combining BOLD-100 with FOLFOX chemotherapy for these conditions.
The study evaluates the safety and effectiveness of BOLD-100 when used with standard chemotherapy. It focuses on understanding how well patients tolerate this combination treatment.
- Who can participate: Participants must be 18 years or older with advanced gastrointestinal tumors and have received only one prior line of therapy in the metastatic setting.
- Study details: Participants will receive BOLD-100 combined with FOLFOX chemotherapy.